comparemela.com

Latest Breaking News On - Mian shakil - Page 1 : comparemela.com

Millrace Asset Group Inc. Has $1.19 Million Position in Augmedix, Inc. (NASDAQ:AUGX)

Millrace Asset Group Inc. decreased its holdings in shares of Augmedix, Inc. (NASDAQ:AUGX – Free Report) by 40.1% in the 4th quarter, HoldingsChannel reports. The firm owned 203,087 shares of the company’s stock after selling 135,745 shares during the period. Millrace Asset Group Inc.’s holdings in Augmedix were worth $1,188,000 as of its most recent […]

Essex
Massachusetts
United-states
Boston
Mian-shakil
Maxim-group
Millrace-asset-group-inc
Russell-investments-group-ltd
Acadian-asset-management
Essex-investment-management-co
Calamos-advisors
Nasdaq

Augmedix, Inc. (NASDAQ:AUGX) Stock Position Reduced by Millrace Asset Group Inc.

Millrace Asset Group Inc. trimmed its position in Augmedix, Inc. (NASDAQ:AUGX – Free Report) by 40.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 203,087 shares of the company’s stock after selling 135,745 shares during the quarter. Millrace Asset Group Inc. owned approximately […]

United-states
Mian-shakil
Millrace-asset-group-inc
Russell-investments-group-ltd
Maxim-group
Perkins-capital-management-inc
Securities-exchange-commission
Vontobel-holding-ltd
Augmedix-inc
Calamos-advisors
Nasdaq
Exchange-commission

Augmedix (NASDAQ:AUGX) Downgraded by Evercore ISI

Evercore ISI lowered shares of Augmedix (NASDAQ:AUGX – Free Report) from an outperform rating to an inline rating in a report issued on Tuesday, MarketBeat reports. They currently have $1.50 price objective on the stock, down from their prior price objective of $5.00. Other research analysts also recently issued reports about the stock. Maxim Group […]

United-states
Mian-shakil
Worth-venture-partners
Sg-americas-securities
Acadian-asset-management
Maxim-group
Augmedix-inc
Nasdaq
Norden-group
Oppenheimer-asset-management-inc
Augmedix-company-profile
Free-report

Augmedix (NASDAQ:AUGX) Rating Lowered to Hold at Maxim Group

Maxim Group lowered shares of Augmedix (NASDAQ:AUGX – Free Report) from a buy rating to a hold rating in a report issued on Tuesday, Marketbeat Ratings reports. The brokerage currently has $5.00 target price on the stock. A number of other equities analysts also recently commented on AUGX. B. Riley started coverage on shares of […]

United-states
Mian-shakil
Securities-exchange-commission
Jump-financial
Maxim-group
Augmedix-inc
Acadian-asset-management
Essex-investment-management-co
Barclays-plc
Worth-venture-partners
Free-report
Marketbeat-ratings

InnovationRx: Battle Of The AI Medical Scribes

InnovationRx: Battle Of The AI Medical Scribes
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

United-states
Americans
Glen-tullman
Manny-krakaris
Mian-shakil
Novo-nordisk
Brixton-biosciences
Google
View-research
Unitedhealth-group
Ai-bot-demystifies-health-insurance
Grand-view-research
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.